Publications by authors named "Sankalp Srivastava"

Intracellular α-ketoglutarate is an indispensable substrate for the Jumonji family of histone demethylases (JHDMs) mediating most of the histone demethylation reactions. Since α-ketoglutarate is an intermediate of the tricarboxylic acid cycle and a product of transamination, its availability is governed by the metabolism of several amino acids. Here, we show that asparagine starvation suppresses global histone demethylation.

View Article and Find Full Text PDF

Amino acid restriction has recently emerged as a compelling strategy to inhibit tumor growth. Recent work suggests that amino acids can regulate cellular signaling in addition to their role as biosynthetic substrates. Using lymphoid cancer cells as a model, we found that asparagine depletion acutely reduces the expression of c-MYC protein without changing its mRNA expression.

View Article and Find Full Text PDF

Tumor cells adapt to nutrient-limited environments by inducing gene expression that ensures adequate nutrients to sustain metabolic demands. For example, during amino acid limitations, ATF4 in the amino acid response induces expression of asparagine synthetase (ASNS), which provides for asparagine biosynthesis. Acute lymphoblastic leukemia (ALL) cells are sensitive to asparagine depletion, and administration of the asparagine depletion enzyme l-asparaginase is an important therapy option.

View Article and Find Full Text PDF

Distinct from normal differentiated tissues, cancer cells reprogram nutrient uptake and utilization to accommodate their elevated demands for biosynthesis and energy production. A hallmark of these types of reprogramming is the increased utilization of, and dependency on glutamine, a nonessential amino acid, for cancer cell growth and survival. It is well-accepted that glutamine is a versatile biosynthetic substrate in cancer cells beyond its role as a proteinogenic amino acid.

View Article and Find Full Text PDF
Article Synopsis
  • Chromosomal translocation is a frequent chromosomal abnormality linked to genetic disorders, infertility, and cancer, but lack of research models has limited progress in understanding and treating these issues.
  • Researchers have successfully used CRISPR/Cas9 technology to create specific chromosomal translocations in mouse embryonic stem cells (mESCs).
  • These modified mESCs can be expanded into stable cell lines and used to generate chimeric mice, providing new models to study translocation effects and develop potential therapies.
View Article and Find Full Text PDF